KODIAK SCIENCES INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
KODIAK SCIENCES INC. (KOD) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2025-03-27
- KODIAK SCIENCES INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was $0.00.
- KODIAK SCIENCES INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$2.00K.
- KODIAK SCIENCES INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was $0.00.
- KODIAK SCIENCES INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$120.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 | |
| 2023-12-31 | -$2.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $0.00 10-K · filed 2025-03-27 | |
| 2021-12-31 | -$120.00K 10-K · filed 2024-03-28 | $120.00K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |